Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SBC Medical Group HoldingsSBC -0.97%21 Debt-to-EBITDA is 0.66 as of Mar. 2026, which is 61% above its 10-year median of 0.41. GuruFocus rates SBC with a GF Score™ of 21/100. The stock has 3 warning signs investors should review. Among 836 Business Services companies, SBC Medical Group Holdings ranks better than 68.06% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for SBC Medical Group Holdings's Debt-to-EBITDA or its related term are showing as below:
SBC'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.16 Med: 0.41 Max: 0.72
Current: 0.72
During the past 4 years, the highest Debt-to-EBITDA Ratio of SBC Medical Group Holdings was 0.72. The lowest was 0.16. And the median was 0.41.
SBC's Debt-to-EBITDA is ranked better than 68.06% of 836
companies
in the Business Services industry
Industry Median: 1.63
vs SBC: 0.72
SBC Medical Group Holdings (NAS:SBC) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
SBC Medical Group Holdings Debt-to-EBITDA Related Terms
SBC Medical Group Holdings Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Consulting Services subindustry, SBC Medical Group Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SBC Medical Group Holdings Debt-to-EBITDA vs Business Services Industry
For the Business Services industry and Industrials sector, SBC Medical Group Holdings's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where SBC Medical Group Holdings's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
SBC Medical Group Holdings (SBC) has a Debt-to-EBITDA of 0.66 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on SBC Medical Group Holdings. This is 61% above median its historical median of 0.41. Over the past decade, SBC Medical Group Holdings' Debt-to-EBITDA has ranged from 0.16 to 0.72. According to the industry distribution chart, SBC Medical Group Holdings ranks #267 out of 836 companies in the Business Services industry, placing it in the top 31.9%.
Is SBC Medical Group Holdings' Debt-to-EBITDA too high?
SBC Medical Group Holdings' current Debt-to-EBITDA of 0.66 is 61% above median its 10-year median of 0.41. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 0.72. The Business Services industry median Debt-to-EBITDA is 1.63. SBC Medical Group Holdings' value of 0.66 is 59.5% below this industry median. Based on the distribution chart, SBC Medical Group Holdings ranks #267 out of 836 companies in the Business Services industry, which is above the industry midpoint. Overall, SBC Medical Group Holdings has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does SBC Medical Group Holdings' Debt-to-EBITDA compare to ROMA and EGG?
According to the Business Services industry distribution chart, SBC Medical Group Holdings ranks #267 out of 836 companies for Debt-to-EBITDA. This puts SBC Medical Group Holdings in the upper half of its industry. The industry median Debt-to-EBITDA is 1.63. SBC Medical Group Holdings' value of 0.66 is 59.5% below this benchmark. Historically, SBC Medical Group Holdings' own Debt-to-EBITDA has ranged from 0.16 to 0.72 over the past decade. While the company's 10-year median is 0.41 vs. the industry median of 1.63, SBC Medical Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Business Services company?
The median Debt-to-EBITDA among Business Services companies is 1.63, based on 836 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SBC Medical Group Holdings's current Debt-to-EBITDA of 0.66 is 59.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on SBC Medical Group Holdings. For the Business Services industry, the median Debt-to-EBITDA is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SBC Medical Group Holdings's current Debt-to-EBITDA is 0.66, which is 61% above median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SBC Medical Group Holdings stock overvalued right now?
SBC Medical Group Holdings (SBC) has a current Debt-to-EBITDA of 0.66. The current Debt-to-EBITDA is 0.66, which is 61% above median its 10-year median of 0.41 and 59.5% below the Business Services industry median of 1.63. SBC Medical Group Holdings' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For SBC Medical Group Holdings (SBC), the current Debt-to-EBITDA is 0.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.
21GF Score
Get the complete analysis for SBC
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBC has been successfully added to your 
